Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol.

Sec. Mucosal Immunity

This article is part of the Research TopicAdvances in Immunity and Strategies Against Mucosal Pathogen Colonization: Innovations in Immunogens and AdjuvantsView all articles

Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations

Provisionally accepted
  • 1Instituto de Investigaciones Biotecnologicas, Buenos Aires, Argentina
  • 2Escuela de Bio y Nanotecnología (EByN), Universidad Nacional de San Martín, Buenos Aires, Argentina
  • 3Hospital Israelita Albert Einstein, São Paulo, Brazil
  • 4Institut Pasteur de São Paulo, Sao Paulo, Brazil
  • 5Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Brazil

The final, formatted version of the article will be published soon.

Keywords: protease inhibitor, Mucosal adjuvant, oral delivery, Antigen degradation, mucosal immunity

Received: 24 Oct 2025; Accepted: 27 Oct 2025.

Copyright: © 2025 Coria, Pueblas Castro, Bruno, Nakaya, Pasquevich and Cassataro. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lorena Mirta Coria, lorecor@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.